Our data also showed that PGE2 produced by thyroid cancer cells blocks NK cell-mediated cytotoxicity (Figure 2), suggesting that targeting the COX-2/PGE2 pathway in thyroid cancer may be an effective therapeutic strategy. This evidence concerns the gene PTGS2 and thyroid cancer.